Table 2. Clinical characteristics of immunoglobulin G (IgG) donors, women with polycystic ovary syndrome (PCOS) and women without the syndrome.
| Controls(n = 4) | PCOS(n = 4) | p-Value | |
|---|---|---|---|
| Age (years) | 27 (22–31) | 25 (23–35) | >0.999 |
| Anthropometry | |||
| BMI (kg/m2) | 26 (19.4–29.8) | 25 (21.3–28.2) | >0.999 |
| Waist-to-hip-ratio | 1 (0.79–0.91) | 1 (0.70–0.91) | 0.857 |
| Endocrine measure | |||
| LH (mU/mL) | 7 (4.40–11.40) | 10 (5.19–38.60) | 0.343 |
| FSH (mU/mL) | 4 (2.74–6.91) | 7 (5.59–8.61) | 0.057 |
| Progesterone (ng/mL) | 10 (0.20–13.60) | 1 (0.60–1.05) | 0.343 |
| Free testosterone (ng/mL) | 2 (0.84–2.68) | 3 (0.29–3.03) | 0.685 |
| Total testosterone (ng/mL) | 0 (0.17–0.40) | 0 (0.30–0.40) | 0.228 |
| Androstenedione (ng/mL) | 3.11 (1.21–4.56) | 4 (1.98–4.69) | 0.685 |
| SHBG (nmol/L) | 63 (52.8–88.8) | 62 (43.9–105) | 0.952 |
| Free androgen index (FAI) | 0 (0.3–0.6) | 1 (0.5–0.7) | 0.171 |
| AMH (ng/mL) | 4 (2.40–4.66) | 8 (4.97–9.96) | 0.028 |
| Metabolic measures | |||
| Cholesterol (mg/dL) | 160 (132–184) | 153 (146–172) | 0.686 |
| HDL (mg/dL) | 77 (42–80) | 62 (49–71) | 0.343 |
| LDL (mg/dL) | 75 (66–89) | 74 (67–107) | 0.828 |
| Triglycerides (mg/dL) | 71 (43–91) | 74 (68–82) | 0.885 |
Data are median ± range. Comparisons between groups were made using Mann–Whitney U-test.
AMH, anti-Müllerian hormone; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SHBG, sex hormone-binding globulin; FSH, follicle-stimulating hormone; LH, luteinizing hormone.